These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 10311021)
1. Formulary system controversies in the new environment of DRGs. Lipman AG Hosp Formul; 1985 Feb; 20(2):218, 221-4, 229 passim. PubMed ID: 10311021 [TBL] [Abstract][Full Text] [Related]
2. Prospective reimbursement and DRGs: implications for formulary management. Enright SM Hosp Formul; 1983 Oct; 18(10):989-90, 999-1000. PubMed ID: 10310246 [No Abstract] [Full Text] [Related]
3. Developing an effective P & T Committee, Part 2. Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830 [TBL] [Abstract][Full Text] [Related]
4. Formularies: the role of pharmacy-and-therapeutics (P&T) committees. Summers KH; Szeinbach SL Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049 [TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomic analysis in formulary decisions: an international perspective. Johnson JA; Bootman JL Am J Hosp Pharm; 1994 Oct; 51(20):2593-8. PubMed ID: 7847423 [TBL] [Abstract][Full Text] [Related]
6. Formulary management to reduce cost: P & T committee strategies. Roberts MJ; Summerfield MR Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289 [TBL] [Abstract][Full Text] [Related]
7. A survey of selective administration procedures in formulary maintenance. Quigley MA; Brown WM Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001 [TBL] [Abstract][Full Text] [Related]
8. P & T Committee formulary requests: criteria for admission. Weintraub M; Guttmacher L Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315 [TBL] [Abstract][Full Text] [Related]
9. Pharmacy formularies in integrated health systems. Osborne JA J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678 [TBL] [Abstract][Full Text] [Related]
10. Developing a unit-of-use drug distribution system for the hospital emergency room. Schiavone JD Hosp Pharm; 1981 Apr; 16(4):208-9, 214-5, 219 passim. PubMed ID: 10251101 [TBL] [Abstract][Full Text] [Related]
11. Developing an effective P&T Committee, Part I. Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL Hosp Formul; 1985 Jul; 20(7):827-8, 837, 841-3 passim. PubMed ID: 10271920 [TBL] [Abstract][Full Text] [Related]
12. Formulary management at a tertiary-care facility: P&T committee interview. Lucas RV; Abramowitz PW Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021 [TBL] [Abstract][Full Text] [Related]
13. Editors' roundtable: Current formulas for P & T Committee success (Part 1). Lipman AG; Neu HC; Singh BN; Weintraub M Hosp Formul; 1987 Mar; 22(3):288-98. PubMed ID: 10312015 [TBL] [Abstract][Full Text] [Related]
14. Improving pharmacy and therapeutics committee operations. Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511 [TBL] [Abstract][Full Text] [Related]
15. How to use structured decision making in developing therapeutic, cost-effective formulary systems. Crane VS Hosp Formul; 1993 Oct; 28(10):859-62, 865-7. PubMed ID: 10129135 [TBL] [Abstract][Full Text] [Related]
16. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital. Benner EJ; Mykita L; Brown K Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233 [TBL] [Abstract][Full Text] [Related]
17. Strategic planning for the management of biotechnologic products: development of a biotech committee. Akinwande K; Tse T; Darab M; Madura A; Cerceo R; Al-Hani A Hosp Formul; 1993 Sep; 28(9):773-4, 777-80. PubMed ID: 10128393 [TBL] [Abstract][Full Text] [Related]
19. P & T committees and the hospital formulary. Evans PJ; Standish RC; Bell JE Hosp Formul; 1983 Sep; 18(9):892-5. PubMed ID: 10262367 [No Abstract] [Full Text] [Related]